|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology and Pharmacology (J.Q., C.X., M.A.B., O.K.R., M.J.K.), Department of Anesthesiology and Perioperative Medicine (O.K.R.), Center for the Study of Weight Regulation and Associated Disorders (J.G.M., W.F.), Division of Neuroscience, Oregon National Primate Research Center (M.A.B., O.K.R.), Oregon Health & Science University, Portland, Oregon
Received May 22, 2007; accepted July 10, 2007
| Abstract |
|---|
|
|
|---|
q phospholipase C (PLC)-protein kinase C
-protein kinase A pathway. We hypothesized that the mER and neurotransmitter receptor signaling pathways converge to control energy homeostasis. Because 5-HT2C receptors mediate many of the effects of serotonin in POMC neurons, we elucidated the common signaling pathways of E2 and 5-HT in guinea pigs using single-cell reverse transcription-polymerase chain reaction (RT-PCR), real time RT-PCR, and whole-cell patch recording. Both 5-hydroxytryptamine2C (5-HT2C) and 5-HT2A receptors were coexpressed in POMC neurons. The 5-HT2A/C agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) desensitized the GABAB response in a dose-dependent manner, which was antagonized by the selective 5-HT2C receptor antagonists 8-[5-(2,4-dimethoxy-5-(4-trifluoromethylphenylsulphonamido) phenyl-5-oxopentyl]1,3,8-triazaspiro[4.5] decane-2,4-dione hydrochloride (RS102221) and 1,2,3, 4,10,14b-hexahydro-2-methyldibenzo [c,f]pyrazino[1,2-a]-azepine hydrochloride (ORG 3363). The 5-HT2C receptor was G
q-coupled to PLC activation and hydrolysis of plasma membrane phosphatidylinositol bisphosphate to directly inhibit GIRK channel activity. Coapplication of the two agonists at their EC50 concentrations (DOI, 20 µM, and E2, 50 nM) produced additive effects. Although there was a significant gender difference in the effects of E2 on baclofen responses, there was no gender difference in 5-HT2C receptor-mediated effects. Finally, both DOI and estrogen (intracerebroventricular) inhibited feeding in ovariectomized female mice. Therefore, the G
q signaling pathways of the mER and 5-HT2C receptors may converge to enhance synaptic efficacy in brain circuits that are critical for maintaining homeostatic functions.
-melanocyte-stimulating hormone-containing neurons (Heisler et al., 2002
It is interesting that serotonin neurons are targets of ovarian and testicular steroids (Bethea, 1993
). These steroid effects have traditionally been attributed to activation of the nuclear receptors (McEwen, 2001
). In nonhuman primates, estrogens up-regulate tryptophan hydroxylase in midbrain 5-HT neurons (Bethea et al., 1998
), decrease serotonin transporter mRNA expression in midbrain raphe (Bethea et al., 1998
), and decrease expression of the 5-HT2C receptor in a number of hypothalamic nuclei (Gundlah et al., 1999
). E2 modulates many of the homeostatic functions through the transcription factors estrogen receptor-
and -β (Couse and Korach, 1999
). However, in contrast to the relatively slow genomic effects of E2, we have identified a putative mER that is G
q-coupled to a PLC-PKC-PKA pathway (Qiu et al., 2003
). E2 reduces the potency of the GABAB receptor agonist baclofen to activate G-protein-coupled inwardly rectifying K+ channels in hypothalamic neurons, and this membrane-delimited signaling pathway also plays a critical role in the control of energy homeostasis (Qiu et al., 2006
).
It is noteworthy that serotoninergic drugs (i.e., selective serotonin reuptake inhibitors) and E2 are effective in alleviating postmenopausal symptoms in women (Stearns et al., 2002
). It may be that E2 and serotonin, via mER and 5-HT2C receptors, respectively, synergize to regulate energy metabolism in postpubertal female patients. Therefore, understanding the actions of E2 and serotonin on POMC neurons may provide insight into fundamental differences between female and male patients in the hypothalamic control of feeding and energy homeostasis. In the present study, we sought to elucidate the cellular cascades activated by 5-HT compared with E2 in hypothalamic POMC neurons using whole-cell recording, scRT-PCR, and real-time RT-PCR techniques and their functional consequences at the whole animal level. Our findings delineate the 5-HT2C signaling pathway in male and female patients and determine its convergence with the mER signaling pathway in arcuate POMC neurons to control energy homeostasis.
| Materials and Methods |
|---|
|
|
|---|
Drugs. All drugs were purchased from Calbiochem (La Jolla, CA) unless otherwise specified. tetrodotoxin (Alomone Labs, Jerusalem, Israel) was dissolved in Milli-Q H2O and further diluted with 0.1% acetic acid (final concentration, 1 mM), pH 4 to 5. E2 was purchased from Steraloids (Wilton, NH), recrystallized to ensure purity, and dissolved in 100% ethanol to a stock concentration of 1 mM. T and DHT (Steraloids) was also dissolved in 100% ethanol. The PKC inhibitors BIS (100 µM) and rottlerin (10 mM), the PLC inhibitor U73122
[GenBank]
(20 mM), the less active analog U73343
[GenBank]
(20 mM), the PI-4-kinase inhibitor wortmannin (10 mM), RS102221 hydrochloride (10 mM), and spiperone hydrochloride (20 mM; Tocris, Ellisville, MO) were dissolved in dimethyl sulfoxide. Phosphatidylinositol bisphosphate (PIP2) was dissolved in the pipette solution at concentration of 5 µM. The solution was sonicated intermittently on ice for 30 min. Sonication was repeated each time before filling a new pipette. DOI (20 mM), m-CPP (10 mM), MK212 (10 mM), and ORG 3363 (20 mM; Organon NV, Oss, The Netherlands) were dissolved in H2O. The G
q binding protein designed to mimic the C terminus of the G
q subunit and the G
s binding protein designed to mimic the C terminus of the G
s subunit were synthesized by PeptidoGenic Research (Livermore, CA). The peptide sequence for G
q peptide was Ac-LGLNLKEYNLV-OH, and the peptide sequence for G
s peptide was CRMHLRQYELL. The peptides were also dissolved in H2O. Aliquots of the stock solutions were stored at -20°C until needed.
Electrophysiology. Adult Topeka guinea pigs were gonadectomized 6 to 10 days before each experiment. Each animal was quickly killed by decapitation, the brain rapidly removed from the skull, and a block containing the hypothalamus immediately dissected. The hypothalamic block was submerged in cold (4°C) oxygenated (95% O2/5% CO2) aCSF containing the following constituents: 124 mM NaCl, 5 mM KCl, 26 mM NaHCO3, 2.6 mM NaH2PO4, 10 mM dextrose, 10 mM HEPES, 2 mM MgSO4, and 2 mM CaCl2 at 4°C. Coronal slices (300–350 µm) through the caudal-rostral extent of the arcuate nucleus were cut with the aid of a vibrating microtome. The slices were transferred to a multiwell auxiliary chamber containing oxygenated aCSF and kept there until electrophysiological recording after
2 h. During recording, slices were maintained in a chamber perfused via a peristaltic pump with warmed (35°C) oxygenated aCSF at a rate of 1.5 ml/min. Microelectrodes (resistances of 3–6 M
) were fabricated from borosilicate glass pipettes (1.5 mm outer diameter) and filled with an internal solution, pH 7.30, containing the following constituents: 128 mM potassium gluconate, 10 mM NaCl, 2 mM MgCl2,11 mM EGTA, 10 mM HEPES, 1 mM ATP, 0.25 mM GTP, and 0.25% biocytin. Standard whole-cell, voltage-clamp procedures were followed using an Axopatch 200A amplifier (Molecular Devices, Sunnyvale, CA). Signals were digitized with a Digidata 1200 and analyzed using pClamp 7.0 software (Molecular Devices). The liquid junctional potential of -10 mV was corrected in the data analysis. Current and voltage traces were also recorded on an analog chart recorder (Gould Instrument Systems, Cleveland, OH). After the formation of a >1 G
seal, intracellular access was achieved by suction, and only those cells that showed less than 10% change in access resistance throughout the recording were included in this study. All of the responses to baclofen were measured in voltage clamp as outward currents (Vhold =-60 mV). For the electrophysiology analysis, only cells with gigaohm or better seals were included in this study.
The protocol for drug administration in the whole-cell patch voltage-clamp experiments (Vhold, -60 mV) was followed as described in a previous publication (Qiu et al., 2003
). After seals were formed and the whole-cell configuration was obtained, slices were perfused with tetrodotoxin (1 µM) for 5 min. The first GABAB receptor-mediated response was generated by perfusing baclofen (at EC50 concentration of 5 µM) until a steady-state outward current was obtained (R1). After drug washout, the current returned to its predrug resting level. The cells were then treated with serotonin receptor agonist drugs DOI and/or other drugs for 15 min, baclofen (5 µM) was perfused again, and R2 was measured. The effects of serotonin receptor agonist drugs or other drugs on the baclofen response are expressed as a percentage of R2 over R1.
Composite dose-response curves were generated from the following logistic equation fitted by computer (Sigma Plot 8.0; SPSS Inc., Chicago, IL) to the data:
Imax = 100 x ([agonist]nH/([agonist]nH + EC50nH)), where
Imax is the maximum outward current for a given agonist, EC50 represents the agonist potency, and nH is the Hill slope.
Immunocytochemistry. After electrical recording, the slices were prepared for fluorescence immunocytochemistry as described previously (Qiu et al., 2003
). In brief, the slices were fixed with 4% paraformaldehyde in Sorensen's phosphate buffer, pH 7.4, for 120 min, immersed overnight in 20% sucrose dissolved in Sorensen's buffer, and frozen in OCT embedding medium (Sakura Finetek, Torrance, CA) and prepared for immunocytochemistry as described previously (Kelly and Rønnekleiv, 1994
). In brief, coronal sections (20 µm) were cut on a cryostat (model 1720 Digital Cryostat; Leitz, Wetzlar, Germany) and mounted on Fisher SuperFrost Plus slides (Fisher Scientific Co., Pittsburgh, PA). Sections were washed for 5 min with 0.1 M sodium phosphate buffer, pH 7.4, and then streptavidin-Cy2 (1:7500–1:10,000; Jackson ImmunoResearch Laboratories Inc., West Grove, PA) was applied for 2 h. The reaction was terminated by washing with buffer. The slices were scanned for the injected neuron with a Nikon (Melville, NY) Eclipse 800 fluorescence microscope. After localization of the biocytin-filled neurons, the slides containing the appropriate sections were processed for the presence of β-endorphin using fluorescence immunohistochemistry as described previously (Kelly and Rønnekleiv, 1994
). In brief, the sections with the biocytin-identified neurons were incubated overnight with a polyclonal β-endorphin antibody (kindly provided by Dr. Robert Eskay, National Institutes of Health, Bethesda, MD) at 1:5000 and washed in 0.1 M phosphate buffer followed by incubation with a donkey anti-rabbit IgG-Cy3 at 1:500 (Jackson ImmunoResearch Laboratories Inc.). The sections were washed with sodium phosphate buffer, and coverslips were applied using a glycerolglycine buffer (2:1), pH 8.6, containing 5% N-propylgallate (Sigma-Aldrich, St. Louis, MO) to reduce photobleaching. Immunostained cells were analyzed and photographed using a Nikon E800 microscope.
Dispersed Single-Cell RT-PCR. Arcuate single-cell harvest from guinea pig hypothalamic slices was performed as described previously (Qiu et al., 2003
). In brief, coronal hypothalamic slices (350 µm) were cut on a vibrating microtome and placed in an auxiliary chamber containing oxygenated aCSF. The slices were allowed to recover for 1 to 2 h in the chamber before dispersion. The arcuate nucleus of the hypothalamus was microdissected and incubated in 2 to 3 ml of aCSF containing 1 mg/ml protease XIV (Sigma-Aldrich) for
15 min at 37°C. The tissue was then washed three times in 1 volume of low-calcium aCSF and two times in normal aCSF. The cells were isolated by trituration with flame-polished Pasteur pipettes, dispersed on a dish, and perfused continuously with aCSF at a rate of 1.5 ml/min. Cells were visualized using a Nikon inverted microscope, and individual neurons were patched and harvested into the patch pipette by applying negative pressure. The content of the pipette was expelled into a siliconized microcentrifuge tube containing 5 µl of the following solution: 0.5 µl of 10x buffer (100 mM Tris-HCl, 500 mM KCl, and 1% Triton X-100; Promega, Madison, WI), 15 U of RNasin (Promega), 0.5 µl of 100 mM DTT, and DEPC-treated water (Ambion, Austin, TX). In addition, hypothalamic tissue was homogenized, and total RNA was extracted using the RNeasy kit (QIAGEN, Valencia, CA) according to the protocol of the manufacturer. The harvested cell solution and 25 ng of hypothalamic total RNA in 1 µl were denatured for 5 min at 65°C and cooled on ice for 5 min, and then single-stranded cDNA was synthesized from cellular RNA by adding 50 U of MLVRT (Applied Biosystems, Foster City, CA), 1.5 µl of 10x buffer, 2 mM MgCl2, 0.2 µl of dNTPs, 15 U of RNasin, 10 mM DTT, 100 ng of random hexamers (Promega), and DEPC-treated water to a final volume of 20 µl. Cells and tissue RNA used as negative controls were processed as described above but without MLVRT. The reaction mixtures were incubated at 42°C for 60 min, denatured at 99°C for 5 min, and cooled on ice for 5 min.
Primers listed in Table 1 were designed using the Clone Manager Software (Scientific and Educational Software, Cary, NC) and synthesized by Invitrogen (Carlsbad, CA). PCR was performed using 3 µl of cDNA template (2 µl for GAPDH) from each RT reaction in a 30 µl of PCR reaction volume containing the following: 3 µl of 10x buffer, 2.4 µl of 25 mM MgCl2 (2 mM final concentration), 0.2 mM dNTPs, 0.2 µM forward and reverse primers, 2 U of TaqDNA polymerase (Promega), and 0.22 µg of TaqStart antibody (Clontech, Mountain View, CA). TaqDNA polymerase and TaqStart antibody were combined and incubated at room temperature for 5 min, and the remainder of the reaction contents was added to the tube and incubated at 94°C for 2 min. PCR reactions for 5-HT1A, 5-HT2A, and 5-HT2C went through 42 to 47 cycles of amplification according to the following protocols: 20-s denaturation (94°C), 30-s annealing (59–62°C), 30-s elongation (72°C), with a final 72°C extension for 5 min. POMC and GAPDH PCR went through 45 and 37 cycles of amplification, respectively, in two steps: 30-s denaturation (94°C), 45-s annealing (65–67°C), with a final 72°C extension for 5 min. Ten microliters of the PCR products were visualized with ethidium bromide on a 1.5% agarose gel.
|
Real-Time RT-PCR. Total RNA was extracted from the microdissected arcuate nucleus of GDX female guinea pigs (n = 6) using the RNAqueous-Micro kit (Ambion). The RNA was treated with DNase I using the DNA-free kit (Ambion) according to manufacturer's instructions and quantified using the NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE). Reverse transcription was carried out with 200 ng of total RNA using 50 U RT (Applied Biosystems), 1.5 µl of 10x buffer, 2 mM MgCl2, 0.2 mM dNTPs, 15 U of RNasin, 10 mM DTT, 100 ng of random hexamers, and DEPC-treated water to a final volume of 20 µl. As a negative control, RNA was processed as described above but without MLVRT. The reaction mixtures were incubated at 42°C for 60 min, denatured at 99°C for 5 min, and cooled on ice for 5 min.
qPCR was performed using an equivalent of 1.5 ng of total RNA (3 µl of a 1:20 dilution of cDNA template), 0.5 µM forward and reverse primers, and the Power SybrGreen PCR Master Mix (Applied Biosystems) in a 20-µl reaction volume. The qPCR reaction for 5-HT2C, 5-HT2A, 5-HT1A, and GAPDH contained 10 µl of 2x Master Mix, 0.5 µM forward and reverse primers, 3 µl of cDNA, and nuclease-free water to a 20 µl final volume. qPCR was performed on samples in the ABI Prism 7500 Fast machine in triplicate under the following conditions: 95°C, 10 min; 40 cycles of amplification at 95°C, 15 s, and 60°C, 1 min followed by a dissociation step for melting point analysis with 35 cycles of 95°C for 15 s, 60°C to 95°C in increments of 1°C for 1 min, and 95°C for 15 s. Standard curves using diluted cDNA from guinea pig hypothalamus (1:5, 1:10, 1:50, 1:100, 1:500) (Fig. 6e) were prepared to determine the efficiency of the primers. The slopes of the standard curves for 5-HT2C, 5-HT2A, 5-HT1A, and GAPDH were -3.1, -3.2, -3.2, and -3.3, respectively (Fig. 6e). The efficiency was calculated for each primer pair using the following formula: E = 10(-1/m) - 1, where m = slope (Livak and Schmittgen, 2001
; Pfaffl, 2001
). The efficiencies were 100% for all transcripts. The similar efficiencies between the primer pairs allowed us to make quantitative estimates between 5-HT2C, 5-HT2A, and 5-HT1A mRNA expression. The amplification data were analyzed by the ABI 7500 System version 1.3.0 software and calculated using the 
CT method (Livak and Schmittgen, 2001
).
|

CT method was used to calculate relative mRNA expression (Livak and Schmittgen, 2001
CT, where
CT = target CT - control CT, 
CT =
CT target -
CT calibrator. Mean and S.E.M. were calculated using Prism 4 software (GraphPad Software Inc., San Diego, CA).
Feeding Study. Eleven- to twelve-week-old female mice anesthetized by intraperitoneal injection of 0.15 ml of mouse cocktail (ketamine-xylazine-saline, 1:1:8) were ovariectomized and then kept anesthetized with isoflurane during the icv cannulation procedure. The mice were placed into a stereotaxic instrument (Cartesian Instruments, Bend, OR), the cranial surface cleaned, and a cannula placed into the third ventricle as described previously (Cepoi et al., 2004
). In brief, a small hole was drilled, and a sterile stainless steel guide cannula (25 gauge, 1.1 cm long, with an obturator stylet placed within) was implanted at midline, 0.825 mm posterior to bregma and 4.8 mm below bregma based on Franklin and Paxinos (1997
). Mice were housed individually and allowed to recover for 10 days. Thereafter, the animals were adapted repeatedly for at least 3 weeks to the experimental procedure, which included a brief restraint in a procedure bag during which time the icv injection was performed. To test the effects of the compounds on feeding after an overnight fast, mice were placed in clean cages with bedding material and free access to water but without food for 16 h (5:00 PM to 9:00 AM). At the end of the fast, each mouse was lightly restrained, the obturator stylet was removed from the guide cannulae, and saline (0.9% NaCl), E2 (0.012 nmol) or DOI (110 nmol) in 2-µl total volume was infused over a 1-min period. Another 1-min period was allowed for diffusion of the drugs before removing the injection needle. The mice were put back into their cages with a preweighed food pellet (Purina Mouse Chow, 5144; Purina, St. Louis, MO). Body weight and pellet weights were determined at 1, 2, 6, and 24 h after injection. The correct cannulae placement was confirmed by injecting methylene blue dye at the end of the study and visualizing the location of the dye in brain slices.
Statistical Analysis. Comparisons between groups were performed using a one-way or two-way ANOVA and Bonferroni post test for the tissue analysis and whole-animal experiments and a one-way ANOVA for the electrophysiological experiments with post hoc Newman-Keuls paired analysis. Differences were considered statistically significant if the probability of error was <5%.
| Results |
|---|
|
|
|---|
versus female guinea pigs: 0.92 ± 0.1 G
) between the two groups. Similar to our previous findings in mice (Qiu et al., 2006
|
|
5-HT2C Receptor-Mediated Attenuation of the GABAB Response Was Dependent on Activation of G
q. Early studies showed that 5-HT2 receptor subtypes couple to G
q protein and activate PLC (de Chaffoy de Courcelles et al., 1985
; Conn et al., 1986
). Therefore, we next examined the involvement of specific signaling proteins in the DOI-mediated modulation. Because 5-HT2A/C receptors are G
q protein-coupled and PKC is the downstream pathway, we first examined whether activation of PKC is critical for DOI modulation of the GABAB response using a PKC inhibitor. If activation of the PKC pathway is involved, then the effect of DOI on GABAB responses should be blocked by inhibiting PKC. To test this, we applied a PKC inhibitor, BIS, which is a selective inhibitor of PKC that does not distinguish between the conventional, novel, and atypical isoforms of PKC, and a selective PKC
inhibitor, rottlerin. We have established that BIS (100 nM) and rottlerin (5 µM) block the inhibition of baclofen responses by E2 (Qiu et al., 2003
). But as shown in Fig. 3, after
15 min of dialysis with BIS (100 nM), the DOI-induced reduction of the GABAB response was not attenuated. Furthermore, both BIS (100 nM) and rottlerin (5 µM) did not block the inhibition of baclofen response by m-CPP, a selective 5-HT2C agonist (p > 0.05, m-CPP, 71.17 ± 2.24, n = 3, versus m-CPP + BIS, 73.16 ± 3.06, n = 7; m-CPP versus m-CPP + rottlerin 68.92 ± 4.01, n = 3). These results indicate that the suppression of the GABAB response by DOI requires PLC activation but not the activation of PKC. To examine whether the DOI-mediated inhibition of the GABAB response depended on the activation of G
q, arcuate neurons were dialyzed with a peptide (11 amino acids) that mimics the C-terminal binding site of G
q. A similar strategy has been used by Carr et al. (2002
) to abrogate 5-HT2 receptor signaling in prefrontal cortical neurons. Indeed, in cells dialyzed with this peptide (200 µM), the DOI-mediated reduction of the GABAB response was blocked significantly (Fig. 3, a and b) compared with cells dialyzed with a control peptide (11 amino acids) that mimics the C-terminal domain of G
s (Fig. 3, a and b).
|
Desensitization of GABAB Response Was Dependent on 5-HT2C Activation of PLC and Hydrolysis of Plasma Membrane PIP2. In light of the above results for a primary role for G
q in DOI-mediated inhibition, we tested whether the activation of PLC might also play a role. Because the specific PKC inhibitor BIS did not block the effects of DOI, this indicated that the PLC, which is downstream from the activation of G
q protein and a well known G
q effector, may be responsible for the DOI effect. Therefore, we focused on pathways downstream of PLC to further elucidate the DOI-mediated signaling pathway. To determine whether the activation of PLC is required for the DOI-induced inhibition of the GABAB response, neurons were treated with the broad-spectrum PLC inhibitor U73122
[GenBank]
(10 µM), which was perfused in the extracellular bathing media. Under these conditions, there was no difference between the first baclofen response and second one in the presence of U73122
[GenBank]
(U73122
[GenBank]
-treated versus control group, 95.57 ± 2.44, n = 3 and 96.48 ± 5.9, n = 5), but the DOI-mediated reduction of GABAB response was blocked (Fig. 3, c and d), whereas the less active PLC inhibitor U73343
[GenBank]
at the same concentration had no effect (Fig. 3, c and d). Furthermore, whole-cell dialysis with PIP2 (5 µM) also attenuated the DOI-mediated inhibition, and there were no significant differences between the first baclofen responses with and without PIP2 dialysis. Moreover, the addition of PI-4-kinase inhibitor wortmannin at 10 µM potentiated the inhibition of DOI on the baclofen response (Fig. 3d). Therefore, the 5-HT2C receptor signals through PLC and PIP2, which is different from the mER signaling pathway (Qiu et al., 2003
). Because DOI and E2 act through divergent G
q signaling pathways, we investigated the convergence of the 5-HT2A/C receptor agonist DOI and E2 on the GABAB response. Concentration-response curves (Fig. 4b) showed that DOI rapidly attenuated the GABAB response in a concentration-dependent manner with 50% inhibition at 16.5 µM for DOI. Therefore, based on the previously published EC50 value (46.0 nM) for the E2-mediated desensitization of the GABAB response (Qiu et al., 2006
), we coapplied both agonists at their EC50 concentrations and found that the effects were additive (Fig. 4, a and c).
|
|
Expression of 5-HT2 Receptor mRNA Transcripts in Arcuate (POMC) Neurons from GDX Guinea Pigs. Based on our electrophysiology results, we examined which serotonin receptors are expressed in arcuate (POMC) neurons in the guinea pig. Previous findings have identified 5-HT2C receptors in male mouse POMC neurons (Heisler et al., 2002
). Using scRT-PCR, we measured 5-HT2C, 5-HT2A, and 5-HT1A receptor transcripts in 54 male and 57 female arcuate neurons, including POMC neurons from 4 animals each (Fig. 6a). Overall, the distribution of these receptors in arcuate neurons was similar in male (69 ± 13, 47 ± 6, and 51 ± 8%; n = 4) and female neurons (81 ± 12, 62 ± 8, and 37 ± 6; n = 4) for 5-HT2C, 5-HT2A, and 5-HT1A receptors, respectively. Based on the frequency of distribution of 5-HT2C, 5-HT2A, and 5-HT1A receptor mRNAs specifically in POMC-positive neurons in GDX female guinea pigs (n = 38 cells), 84% of these neurons expressed 5-HT2C receptor mRNA, 76% expressed 5-HT2A receptor mRNA, and 42% expressed 5-HT1A receptor mRNA (Fig. 6b). The degree of coexpression of these receptors in POMC neurons was also determined as illustrated in Fig. 6b and was found to be 71% for 5-HT2A and 5-HT2C and 26% for all three receptors (Fig. 6b). Using RT and real-time PCR to quantify the level of expression of serotonin receptor mRNAs in the microdissected arcuate nucleus, we found that 5-HT2A receptors were most highly expressed followed by 5-HT2C receptors (Fig. 6, c–f; p < 0.05). The expression of 5-HT1A was significantly lower than that of 5-HT2A and 5-HT2C receptor transcripts (p < 0.001; Fig. 6, c–f). Therefore, the scRT-PCR and qPCR data support the electrophysiological data that 5-HT2C and 5-HT2A receptors are highly expressed in the arcuate and coexpressed in the majority of POMC neurons.
| Discussion |
|---|
|
|
|---|
q-coupled receptor desensitized the GABAB response in neurons. Short-term activation of the mER with E2 also desensitized the GABAB receptor response, but unlike the mER signaling pathway, the 5-HT2C receptor pathway led to direct hydrolysis of PIP2 to affect GIRK channel function. Although there was a clear gender difference in the efficacy of E2 to activate mER, there was no difference in the 5-HT2C-mediated response between male and female guinea pigs. Finally, E2 and the 5-HT2C agonist DOI, albeit at a higher dose, were effective in reducing food intake and body weight gain in fasted, GDX female guinea pigs, which highlights the physiological importance of the mER and 5-HT2C signaling pathways in mediating POMC neuronal excitability.
Serotonin affects arcuate (POMC) neuronal activity through multiple receptor-mediated mechanisms. Both 5-HT2A and 5-HT2C receptors are localized to the medial basal hypothalamus, and activation of these G
q-coupled receptors excites these neurons (Wright et al., 1995
; Heisler et al., 2002
). In particular, POMC neurons are excited in response to d-fenfluramine, 5-HT, or 5-HT2C receptor agonists like m-CPP and MK212 (Heisler et al., 2002
). However, the underlying mechanism(s) for the excitation of hypothalamic neurons has not been elucidated. Our data show that the G
q/PLC-coupled pathway of 5-HT2A/C receptors causes an inhibition of the baclofen response, and we provide the first evidence that depletion of PIP2, rather than the phosphorylation of the channel, is a key step in this pathway based on the following: First, PKC inhibitors did not block the inhibition of the baclofen response by the 5-HT2A/C receptor agonist DOI or 5-HT2C receptor agonist m-CPP. Second, the DOI-mediated reduction of the GABAB response was significantly attenuated by the PLC inhibitor U73122
[GenBank]
compared with cells perfused with the less active inhibitor U73343.
[GenBank]
Third, whole-cell dialysis with PIP2 attenuated the DOI inhibition of the GABAB response, and the addition of wortmannin greatly potentiated the inhibition of DOI on baclofen responses. Finally, intracellular dialysis with a peptide fragment of G
q abrogated the 5-HT2C receptor interaction with G-protein, which indicates that 5-HT2A/C receptors are specifically coupled to G
q protein. Thus, we conclude that 5-HT2A/C receptor-mediated inhibition of GIRK channels involves PLC activation by G
subunits of the G
q family and that the receptor-mediated hydrolysis of plasma membrane PIP2 is the critical mediator. It is worth noting that although both 5-HT2A and 5-HT2C receptors are G
q-coupled, the inhibition of the baclofen response in POMC neurons is mainly through the 5-HT2C receptor because the 5-HT2C-selective agonists m-CPP and MK212 attenuated baclofen responses in POMC neurons. Moreover, the selective 5-HT2C antagonists ORG 3363 and RS102221 but not the 5-HT2A antagonist spiperone potently blocked the actions of DOI in guinea pig arcuate (POMC) neurons, indicating that the inhibition of the GABAB response is through the 5-HT2C receptor. This is compatible with previous findings that the 5-HT2C receptor agonists show greater efficacy for activating the PLC pathway, whereas 5-HT2A receptor agonists have relatively greater efficacy for activating the phospholipase A2 pathway (Berg et al., 1998
; Kurrasch-Orbaugh et al., 2003
). The PLC hydrolysis of PIP2 and inhibition of GIRK channels is not unique to 5-HT2C receptors because other G
q-coupled receptors have different propensities for activating this pathway depending on the subcellular localizations of the G-protein-coupled receptor relative to the proximity of PLC and GIRK channels (Cho et al., 2005
).
It is interesting that GABAB, µ-opioid, and 5-HT1A receptors are all expressed in POMC neurons (Kelly et al., 1992
; Lagrange et al., 1994
; Qiu et al., 2003
; present findings). All of these receptors are G
i/o-coupled to activation of GIRK channels, which uniformly inhibit POMC neuronal activity. Similar to our findings with the 5-HT2C receptor-mediated desensitization of the GABAB response in POMC neurons, activation of 5-HT2A receptors can desensitize 5-HT1A receptors and increase the excitability of CRH neurons, as measured by ACTH release (Zhang et al., 2001
). The heterologous desensitization in these paraventricular nucleus neurons has not been characterized but may be via PKC-mediated phosphorylation of GIRK channels (Brown et al., 2005
) or by PLC-mediated PIP2 depletion (Brown et al., 2005
; Cho et al., 2005
). Therefore, the PLC-mediated PIP2 depletion maybe a common signaling pathway for 5-HT2A/C receptors in hypothalamic neurons.
|
Serotonin 5-HT2C receptors have also been strongly implicated in inhibiting feeding. For example, the selective 5-HT2C antagonist RS102221 increases food intake and body weight when injected intraperitoneally (Bonhaus et al., 2006
), and 5-HT2C receptor-deficient mice are hyperphagic, obese, and refractory to threshold anorexic doses of d-fenfluramine (Tecott et al., 1995
; Vickers et al., 1999
), a drug that blocks the reuptake of 5-HT and stimulates its release (Heal et al., 1998
). In contrast, 5-HT2A receptor knockout mice do not exhibit an obesity phenotype, so one may assume that 5-HT2A receptors are not critically involved in energy homeostasis (Zhou et al., 2005
). We found that 5-HT2C mRNA was highly expressed and colocalized with 5-HT2A receptor in POMC neurons. This would disagree with in situ hybridization results in rhesus (female) monkeys showing that 5-HT2C receptor mRNA is highly expressed in the arcuate region, whereas the 5-HT2A receptor mRNA is more localized to the PVN (Gundlah et al., 1999
). In addition, Heisler et al. (2002
) found that up to 80% of POMC neurons express 5-HT2C receptor mRNA. However, the role of the 5-HT2C and 5-HT2A receptors in different physiological processes may lie in their coupling to distinctive signaling pathways.
Based on our cellular electrophysiological data, we have proposed a model for the convergence of the mER and 5-HT2C signaling pathways in arcuate (POMC) neurons (Fig. 7). It is noteworthy that the downstream signaling pathway of baclofen inhibition by 5-HT2C receptor agonists in arcuate (POMC) neurons is different from mER in which E2 desensitizes the GABAB response via a G
q-PLC-PKC
-PKA pathway (Qiu et al., 2003
). These differences may be due to the different compartmentalization of the receptors. It has been reported that the signaling components for G-protein activation in neurons are compartmentalized or preassembled (Lober et al., 2006
). G-protein-coupled receptors, G-proteins, and other effector molecules can preassemble into stable signaling complexes (Rebois and Hebert, 2003
). Therefore, the 5-HT2C receptor and mER may be preassembled into complexes with different downstream effectors that converge on GIRK channels. For example, Brown and colleagues (2005
) have shown that although protein kinases (i.e., PKC
) mediate the inhibition of GIRK1/2 channels by the muscarinic M3 receptor, resynthesis of PIP2 is required for complete recovery from inhibition. Therefore, PIP2 turnover is critical for GIRK channel function. Our data support this idea because 5-HT2C receptors can inhibit the GIRK channels by an independent pathway from mER, but the two pathways converge on the same population of GIRK channels as shown by the additive effects of the two agonists given together. As proof of principle, we have found that both E2 and DOI are effective to inhibit feeding in GDX female mice, and as predicted from the cellular findings, E2 was more potent than DOI to inhibit food intake and weight gain. Therefore, the G
q signaling pathways of mER and 5-HT2C receptors may converge to enhance synaptic efficacy in brain circuits that are critical for maintaining homeostatic functions.
| Acknowledgements |
|---|
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
ABBREVIATIONS: POMC, proopiomelanocortin; E2,17β-estradiol; GABAB,
-amino butyric acid B receptor; GIRK, G protein-coupled inwardly rectifying potassium; mER, membrane estrogen receptor; PLC, phospholipase C; PKC
, protein kinase C
; PCR, polymerase chain reaction; PKA, protein kinase A; 5-HT, 5-hydroxytryptamine, serotonin; RT-PCR, reverse transcription-polymerase chain reaction; scRT-PCR, single-cell reverse transcription-polymerase chain reaction; qPCR, quantitative polymerase chain reaction; DOI, (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane; RS102221, 8-[5-(2,4-dimethoxy-5-(4-trifluoromethylphenylsulphonamido) phenyl-5-oxopentyl] 1,3,8-triazaspiro[4.5] decane-2,4-dione hydrochloride; ORG 3363, 1,2,3,4,10,14b-hexahydro-2-methyldibenzo [c,f]pyrazino[1,2-a]azepine hydrochloride, R-enantiomer; PIP2, phosphatidylinositol 4,5 bisphosphate; icv, intracerebroventricular; PVN, paraventricular nucleus; GDX, gonadectomized; BIS, bisindolymaleimide I hydrochloride; DHT, dihydrotestosterone; wortmannin, (1S,6br,9aS,11R,11bR) 11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-3H-furo [4,3,2-de]indeno[4,5,-h]-2-h-2-benzopyran-3,6,9-trione; spiperone, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one hydrochloride; m-CPP, 1-(3-chlorophenyl)piperazine hydrochloride; MK212, 6-chloro-2-(1-piperazinyl) pyrazine hydrochloride; aCSF, artificial cerebral spinal fluid; DTT, dithiothreitol; DEPC, diethylpyrocarbonate; MLVRT, murine leukemia virus reverse transcriptase; CT, cycle threshold; PI, phosphatidylinositol; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ANOVA, analysis of variance; T, testosterone; IP3, inositol 1,4,5 triphosphate; DAG, diacylglycerol; U73122
[GenBank]
, 1-[6-[[17β-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione; U73343
[GenBank]
, 1-[6-[[17β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidine-dione.
Address correspondence to: Dr. Jian Qiu, Department of Physiology and Pharmacology, L334, Oregon Health and Science University, Portland, OR 97239-3098. E-mail: qiuj{at}ohsu.edu
| References |
|---|
|
|
|---|
Bethea CL (1993) Colocaliztion of progestin receptors with serotonin in Raphe neurons of Macaque. Neuroendocrinology 57: 1-6.[Medline]
Bethea CL, Pecins-Thompson M, Schutzer WE, Gundlah C, and Lu ZN (1998) Ovarian steroids and serotonin neural function. Mol Neurobiol 18: 87-123.[Medline]
Bickerdike MJ (2003) 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Top Med Chem 3: 885-897.[CrossRef][Medline]
Bonhaus SJ, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontan DJ, Trinh J, Rocha CL, and Dawson MW (2006) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36: 621-629.
Breisch ST, Zemlan FP, and Hoebel BG (1976) Hyperphagia and obesity following serotonin depletion by intraventricular P-chlorophenylalanine. Science 192: 382-385.
Brown SG, Thomas A, Dekker LV, Tinker A, and Leaney JL (2005) PKC-
sensitizes Kir3.1/3.2 channels to changes in membrane phospholipid levels after M3 receptor activation in HEK-293 cells. Am J Physiol Cell Physiol 289: C543-C556.
Butera PC and Czaja JA (1984) Intracranial estradiol in ovariectomized guinea pigs: Effects on ingestive behaviors and body weight. Brain Res 322: 41-48.[CrossRef][Medline]
Carr DB, Cooper DC, Ulrich SL, Spruston N, and Surmeier DJ (2002) Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism. J Neurosci 22: 6846-6855.
Cepoi D, Phillips T, Cismowski M, Goodfellow VS, Ling N, Cone RD, and Fan W (2004) Assessment of a small molecule melancortin-4 receptor-specific agonist on energy homeostasis. Brain Res 1000: 64-71.[CrossRef][Medline]
Cho H, Lee D, Lee SH, and Ho WK (2005) Receptor-induced depletion of phosphatidylinositol 4,5-bisphosphate inhibits inwardly rectifying K+ channels in a receptor-specific manner. Proc Natl Acad Sci U S A 102: 4643-4648.
Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8: 571-578.[CrossRef][Medline]
Conn PJ, Sanders-Bush E, Hoffman B, and Hartig PR (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci U S A 83: 4086-4088.
Couse JF and Korach KS (1999) Estrogen receptor null mice: What have we learned and where will they lead us? Endocr Rev 20: 358-417.
Czaja JA (1984) Sex differences in the activational effects of gonadal hormones on food intake and body weight. Physiol Behav 33: 553-558.[CrossRef][Medline]
Czaja JA and Goy RW (1975) Ovarian hormones and food intake in female guinea pigs and Rhesus monkeys. Horm Behav 6: 329-349.[CrossRef][Medline]
de Chaffoy de Courcelles D, Leysen JE, de Clerck F, Van Belle H, and Janssen PA (1985) Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biol Chem 260: 7603-7608.
Elmquist JK, Elias CF, and Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221-232.[CrossRef][Medline]
Franklin KBJ and Paxinos G (1997) Atlas of the Mouse Brain. Academic Press, San Diego, CA.
Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, Plum L, Balthasar N, Hampel B, Waisman A, et al. (2005) Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8: 1289-1291.[CrossRef][Medline]
Gundlah C, Pecins-Thompson M, Schutzer WE, and Bethea CL (1999) Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in Macaque hypothalamus. Mol Brain Res 63: 325-339.[Medline]
Heal DJ, Cheetham SC, Prow MR, Martin KF, and Buckett WR (1998) A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents. Br J Pharmacol 125: 301-308.[CrossRef][Medline]
Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, et al. (2002) Activation of central melanocortin pathways by fenfluramine. Science 297: 609-611.
Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, Liu HY, Zigman JM, Balthasar N, Kishi T, et al. (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51: 239-249.[CrossRef][Medline]
Kelly MJ, Loose MD, and Rønnekleiv OK (1992) Estrogen suppresses µ-opioid and GABAB-mediated hyperpolarization of hypothalamic arcuate neurons. J Neurosci 12: 2745-2750.[Abstract]
Kelly MJ and Rønnekleiv OK (1994) Electrophysiological analysis of neuroendocrine neuronal activity in hypothalamic slices, in Methods in Neurosciences: Pulsatility in Neuroendocrine Systems (Levine JE ed) pp 47-67, Academic Press, Inc., San Diego.
Kurrasch-Orbaugh DM, Watts VJ, Barker EL, and Nichols DE (2003) Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J Pharmacol Exp Ther 304: 229-237.
Lagrange AH, Rønnekleiv OK, and Kelly MJ (1994) The potency of µ-opioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17β-estradiol. J Neurosci 14: 6196-6204.[Abstract]
Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-
CT method. Methods 25: 402-408.[CrossRef][Medline]
Lober RM, Pereira MA, and Lambert NA (2006) Rapid activation of inwardly rectifying potassium channels by immobile G-protein-coupled receptors. J Neurosci 26: 12602-12608.
Luquet S, Perez FA, Hnasko TS, and Palmiter RD (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310: 683-685.
McEwen BS (2001) Estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Physiol 91: 2785-2801.
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Rønnekleiv OK, and Kelly MJ (2003) Rapid signaling of estrogen in hypothalamic neurons involves a novel G protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23: 9529-9540.
Qiu J, Bosch MA, Tobias SC, Krust A, Graham S, Murphy S, Korach KS, Chambon P, Scanlan TS, Rønnekleiv OK, et al. (2006) A G protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J Neurosci 26: 5649-5655.
Rebois RV and Hebert TE (2003) Protein complexes involved in heptahelical receptor-mediated signal transduction. Receptors Channels 9: 169-194.[CrossRef][Medline]
Södersten P, Bergh C, and Zandian M (2006) Understanding eating disorders. Horm Behav 50: 572-578.[CrossRef][Medline]
Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, and Hayes DF (2002) Hot flushes. Lancet 360: 1851-1861.[CrossRef][Medline]
Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, and Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374: 542-546.[CrossRef][Medline]
Vickers SP, Clifton PG, Dourish CT, and Tecott LH (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice. Psychopharmacology (Berl) 143: 309-314.[CrossRef][Medline]
Wright DE, Seroogy KB, Lungren KH, Davis BM, and Jennes L (1995) Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351: 357-373.[CrossRef][Medline]
Zhang Y, D'Souza D, Raap DK, Garcia F, Battaglia G, Muma NA, and Van de Kar LD (2001) Characterization of the functional heterologous desensitization of hypothalamic 5-HT1A receptors after 5-HT2A receptor activation. J Neurosci 21: 7919-7927.
Zhou L, Williams T, Lachey JL, Kishi T, Cowley MA, and Heisler LK (2005) Serotonergic pathways converge upon central melanocortin systems to regulate energy balance. Peptides 26: 1728-1732.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
C. Zhang, M. A. Bosch, O. K. Ronnekleiv, and M. J. Kelly {gamma}-Aminobutyric Acid B Receptor Mediated Inhibition of Gonadotropin-Releasing Hormone Neurons Is Suppressed by Kisspeptin-G Protein-Coupled Receptor 54 Signaling Endocrinology, May 1, 2009; 150(5): 2388 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Roepke, C. Xue, M. A. Bosch, T. S. Scanlan, M. J. Kelly, and O. K. Ronnekleiv Genes Associated with Membrane-Initiated Signaling of Estrogen and Energy Homeostasis Endocrinology, December 1, 2008; 149(12): 6113 - 6124. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Lam, M. J. Przydzial, S. H. Ridley, G. S. H. Yeo, J. J. Rochford, S. O'Rahilly, and L. K. Heisler Serotonin 5-HT2C Receptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors Endocrinology, March 1, 2008; 149(3): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||